Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Exploratory Trial of the "HiDongDong" Language Rehabilitation App for Articulation Delay.

NCT: NCT07613268 · NOT_YET_RECRUITING

NCT IDNCT07613268
StatusNOT_YET_RECRUITING
SponsorSeoul National University Bundang Hospital (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the effectiveness of the AI-based application "HiDongDong" in improving articulation development in children aged 2 to under 14 years with suspected articulation delays. The program provides individualized language training based on a personalized assessment of vulnerable speech sounds. This trial aims to determine whether the digital therapeutic solution can enhance articulation skills and inform future strategies for language rehabilitation in children.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑